Predictors of b/tsDMARDs discontinuation and treatment response in psoriatic arthritis: results from the British Society for Rheumatology Psoriatic Arthritis Register (BSR-PsA).
OBJECTIVES Despite advances in biologic and targeted synthetic DMARDs (b/tsDMARDs), many patients with psoriatic arthritis (PsA) experience suboptimal responses and discontinue therapy. We aimed, in a real-world registry, to identify predictors of b/tsDMARD discontinuation and treatment response. METHODS Patients com...